Chromosomes,cancer and cancer genome Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Cancer is a disease of the genome

A

genetic alteration leads to altered protein expression to altered biology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

features in cancer genomes

A

aneuploidy
copy number changers
double minutes
chromthripsis
epigenetic
translocation
point mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chromosomal instability (CIN)

A

loss or gain or rearrangement of chromosomes
prognostic hallmark of cancers
thought to arise due to errors in chromosome duplication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

types of CIN

A

numerical - gains or loss
Structureal - gain or loss of chromosomal regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Aneuploidy

A

change in number of chromosomes
common in cancer
due to defects in chromosome segregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

copy number alterations

A

occur across tumour types
whats important is whats in that region being amplified or deleted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

double minutes

A

Extrachromasomal circular fragments
replicate in nucleus
lack centromere and telomeres
evolve with tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

chromothripsis

A

chromsome shattering and random reassembly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Translocation

A

when one chromosomal region is moved to another
can be balanced or imbalanced - depneding on gain or loss of dna material
can cause fusion genes
within a chromsome can cause inversions where you flip a gene inside a chromsome can give fusion genes
drug for this ALK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

fusion genes

A

hybrid genes from two seperate ghenes
can lead to functional proteins with oncogenic properties
drug target for drugs like imatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Telomeres

A

repetative structure at chromosome end
protect against chromosome fusion
overcome end replication problem - replication cant go all the way to end of chromosome we lose some at each division and telomere prevents this
in cancer they are regenerated by telomerase
active in stem cells and 90% of cancer

ALT
found in 10% of canc
in certain cancers
poor prognosis through chromosome instability
mediated by homologous recomb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Point mutations

A

insertions/deletions(frame shift)
substitution(silent-same amino acid, missense-wrong amino acid, nonsense-introduce stop codon etc).

cancer cells have high mutation burden

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cancer is a multistage process

A

no single mutation is enough
cells accumulate mutations each one can effect different hallmark of proliferation
mutation range is different across different cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Driver mutation

A

causally implicated in cancer
if a mutation is commonly scene in cancers it is a driver mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

passenger mutation- does not contribute to cancer

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

functional classes of significantly mutated genes

A
17
Q

Breast cancer point mutations

A

thousands of mutations found in breast cancer with around 2/3 missense 1/3 silent and 5% nonsense

18
Q

Epigenetic mechanisms 3 types

A

DNA methylation
histone modification
non coding RNAs

19
Q

DNA methylation

A

addition of methyl group by dna methytransferase
repetitive sequences
found in CpG islands in promoters
transcriptional repression
in cancer - local hypermethylation - TSGs maybe turned off
global hypomethylation - loss of methylation such as repetitive sequence and allows chromosomal instability

20
Q

Histone modifications

A

acetylated
phosphorylated
methylated

affects dna compactment
global changes in this - level of modifiers, modification profiles
modifiers can be mutated in cancer
HDAC inhibitors as therapy